Fogel R, Michelson G, Senler T, Marshall D, Brown T, Gaginella T
Gastroenterology. 1987 Aug;93(2):330-4. doi: 10.1016/0016-5085(87)91023-7.
Two types of benzodiazepine receptors have been identified in the central nervous system. The aim of these experiments was to determine if ligands for these receptors alter basal water absorption by rat ileum in vivo after central administration. Specifically, the effects on net water flux of the systemic and central administration of diazepam and the central administration of RO 5-4864, a "peripheral" receptor agonist, and of the "central" receptor agonists clonazepam and lorazepam were determined. Diazepam increased absorption at 4.3 mg/250 g body wt i.p. but not at 430 micrograms/250 g body wt. Intracerebroventricular diazepam (28 micrograms) increased water absorption. Larger doses had a greater effect. Intracerebroventricular RO 5-4864 (100 micrograms) increased net water absorption; intracerebroventricular lorazepam (50 or 100 micrograms) or clonazepam (100 micrograms) reduced basal water absorption. Systemic atropine (2 mg/kg i.v.) abolished the effect of lorazepam (100 micrograms i.c.v.). To evaluate the possibility that diazepam and RO 5-4864 have effects similar to those of calcium channel antagonists, nifedipine, nitrendipine, and diltiazem were administered intracerebroventricularly. The dihydropyridine calcium channel antagonists nifedipine and nitrendipine increased basal water absorption. Diltiazem, a benzothiazepine compound, did not alter basal water absorption. We conclude that the binding of benzodiazepine agonists to receptors located in the central nervous system alters net water absorption by the rat ileum. Agonists of the central benzodiazepine receptor reduce basal water absorption via a cholinergic neural pathway. Peripheral agonists increase net water absorption. In this model, diazepam behaves as a peripheral receptor agonist. This study provides further evidence of a role for the central nervous system in the regulation of intestinal absorption of water and ions.
在中枢神经系统中已鉴定出两种类型的苯二氮䓬受体。这些实验的目的是确定这些受体的配体在中枢给药后是否会改变大鼠回肠在体内的基础水吸收。具体而言,测定了地西泮全身给药和中枢给药以及“外周”受体激动剂RO 5-4864和“中枢”受体激动剂氯硝西泮及劳拉西泮中枢给药对净水流的影响。地西泮腹腔注射4.3mg/250g体重时增加了水吸收,但430μg/250g体重时未增加。脑室内注射地西泮(28μg)增加了水吸收。剂量越大效果越明显。脑室内注射RO 5-4864(100μg)增加了净水吸收;脑室内注射劳拉西泮(50或100μg)或氯硝西泮(100μg)降低了基础水吸收。静脉注射全身阿托品(2mg/kg)消除了劳拉西泮(脑室内注射100μg)的作用。为了评估地西泮和RO 5-4864是否具有与钙通道拮抗剂类似的作用,将硝苯地平、尼群地平和地尔硫䓬脑室内给药。二氢吡啶类钙通道拮抗剂硝苯地平和尼群地平增加了基础水吸收。苯并硫氮䓬类化合物地尔硫䓬未改变基础水吸收。我们得出结论,苯二氮䓬激动剂与位于中枢神经系统的受体结合会改变大鼠回肠的净水吸收。中枢苯二氮䓬受体激动剂通过胆碱能神经通路降低基础水吸收。外周激动剂增加净水吸收。在这个模型中,地西泮表现为外周受体激动剂。这项研究进一步证明了中枢神经系统在调节肠道水和离子吸收中的作用。